Renaissance Technologies's EHC Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 71,000 shares of Encompass Health Corporation (EHC) worth $9.02 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in EHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 660,400 shares. Largest reduction occurred in Q2 2019, reducing 1.13 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Encompass Health Corporation (EHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Encompass Health Corporation (EHC) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2018 | +411,100 | New Buy | 411,100 | $57.17 |
| Q2 2018 | +458,100 | Add 111.43% | 869,200 | $67.72 |
| Q3 2018 | +628,300 | Add 72.28% | 1.5 M | $77.95 |
| Q4 2018 | +660,400 | Add 44.10% | 2.16 M | $61.70 |
| Q1 2019 | +80,100 | Add 3.71% | 2.24 M | $58.40 |
| Q2 2019 | -1.13 M | Reduce 50.60% | 1.11 M | $63.36 |
| Q3 2019 | -744,968 | Reduce 67.39% | 360,532 | $63.28 |
| Q4 2019 | -360,532 | Sold Out | 360,532 | $0.00 |
| Q1 2020 | +188,900 | New Buy | 188,900 | $64.03 |
| Q2 2020 | +94,500 | Add 50.03% | 283,400 | $61.93 |
| Q3 2020 | -208,100 | Reduce 73.43% | 75,300 | $64.98 |
| Q4 2020 | -75,300 | Sold Out | 75,300 | $0.00 |
| Q3 2021 | +90,100 | New Buy | 90,100 | $75.04 |
| Q4 2021 | +135,200 | Add 150.06% | 225,300 | $65.26 |
| Q1 2022 | +239,300 | Add 106.21% | 464,600 | $71.11 |
| Q2 2022 | -403,500 | Reduce 86.85% | 61,100 | $56.06 |
| Q3 2022 | +259,800 | Add 425.20% | 320,900 | $45.23 |
| Q4 2022 | -316,800 | Reduce 98.72% | 4,100 | $0.06 |
| Q1 2023 | -4,100 | Sold Out | 4,100 | $0.00 |
| Q3 2024 | +31,200 | New Buy | 31,200 | $96.64 |
| Q4 2024 | +19,700 | Add 63.14% | 50,900 | $92.35 |
| Q2 2025 | +1,500 | Add 2.95% | 52,400 | $122.63 |
| Q3 2025 | +18,600 | Add 35.50% | 71,000 | $127.02 |
Renaissance Technologies's Encompass Health Corporation Investment FAQs
Renaissance Technologies first purchased Encompass Health Corporation (EHC) in Q1 2018, acquiring 411,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Encompass Health Corporation (EHC) for 31 quarters since Q1 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Encompass Health Corporation (EHC) was in Q4 2018, adding 2,157,900 shares worth $133.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 71,000 shares of Encompass Health Corporation (EHC), valued at approximately $9.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Encompass Health Corporation (EHC) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Encompass Health Corporation (EHC) was 2,238,000 shares, as reported at the end of Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.